Antiviral activity of shiga toxin requires enzymatic activity and is associated with increased permeability of the target cells

scientific article

Antiviral activity of shiga toxin requires enzymatic activity and is associated with increased permeability of the target cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/IAI.71.1.327-334.2003
P932PMC publication ID143405
P698PubMed publication ID12496182
P5875ResearchGate publication ID6145805

P50authorCarolyn Hovde BohachQ30029030
P2093author name stringIndira Basu
Witold A Ferens
Diana M Stone
P2860cites workEvidence that glutamic acid 167 is an active-site residue of Shiga-like toxin IQ24651553
Prevalence and some properties of verotoxin (Shiga-like toxin)-producing Escherichia coli in seven different species of healthy domestic animalsQ24655713
Crystal structure of the holotoxino from Shigella dysenteriae at 2.5 Å resolutionQ27729840
Antiviral immunotoxins: antibody-mediated delivery of gelonin inhibits Pichinde virus replication in vitroQ28321430
Ribosome-inactivating proteins from plants: present status and future prospectsQ29301419
The Epidemiology of Infections Caused by Escherichia coli O157: H7, Other Enterohemorrhagic E. coli, and the Associated Hemolytic Uremic SyndromeQ33375970
Endothelial heterogeneity in Shiga toxin receptors and responses.Q33493734
Disruption of an internal membrane-spanning region in Shiga toxin 1 reduces cytotoxicityQ33767533
Cattle lack vascular receptors for Escherichia coli O157:H7 Shiga toxinsQ33916632
Prevalence and characterization of Shiga toxin-producing Escherichia coli isolated from cattle, food, and children during a one-year prospective study in FranceQ33965946
Stx2 subtyping of Shiga toxin-producing Escherichia coli isolated from cattle in France: detection of a new Stx2 subtype and correlation with additional virulence factorsQ33973300
Prevalence and characteristics of shiga toxin-producing Escherichia coli from healthy cattle in JapanQ33988749
Viral infection permeabilizes mammalian cells to protein toxinsQ72864905
Elastase in intestinal mucus enhances the cytotoxicity of Shiga toxin type 2dQ73396639
A longitudinal study of Shiga-toxigenic Escherichia coli (STEC) prevalence in three Australian diary herdsQ73425595
Usefulness of a commercially available enzyme immunoassay for Shiga-like toxins I and II as a presumptive test for the detection of Escherichia coli O157:H7 in cattle fecesQ73597464
Antiviral activity of shiga toxin 1: suppression of bovine leukemia virus-related spontaneous lymphocyte proliferationQ34007607
Virus resistance mediated by ribosome inactivating proteinsQ34070134
Shiga toxin: purification, structure, and functionQ34115810
Modification of membrane permeability by animal viruses.Q34314053
A novel mechanism for inhibition of translation by pokeweed antiviral protein: depurination of the capped RNA templateQ34362464
Correlation of enterohemorrhagic Escherichia coli O157 prevalence in feces, hides, and carcasses of beef cattle during processingQ35102179
Serum antibody responses of cattle following experimental infection with Escherichia coli O157:H7Q35493730
Translocation of Shiga toxin across polarized intestinal cells in tissue cultureQ35512892
Evidence that the A2 fragment of Shiga-like toxin type I is required for holotoxin integrityQ35779632
The prevalence of proviral bovine leukemia virus in peripheral blood mononuclear cells at two subclinical stages of infection.Q35858482
C-terminal deletion mutant of pokeweed antiviral protein inhibits viral infection but does not depurinate host ribosomesQ36106591
Escherichia coli O157:H7 in beef cattle presented for slaughter in the U.S.: higher prevalence rates than previously estimatedQ36198411
Evidence that the spontaneous blastogenesis of lymphocytes from bovine leukemia virus-infected cattle is viral antigen specificQ36428570
Escherichia coli O157:H7 in microbial flora of sheepQ36527889
In vivo leukocyte tropism of bovine leukemia virus in sheep and cattle.Q36622894
Detection and characterization of fecal verotoxin-producing Escherichia coli from healthy cattleQ37185235
TAP 29: an anti-human immunodeficiency virus protein from Trichosanthes kirilowii that is nontoxic to intact cellsQ37557684
Relationship between lymphosarcoma and persistent lymphocytosis in cattle: a reviewQ38055928
Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramideQ38350915
Occurrence of Shiga toxin-producing Escherichia coli in fecal samples from children with diarrhea and from healthy zebu cattle in UgandaQ38885135
Bovine enzootic leukosisQ40016872
Expression of the Bovine Leukemia Virus and Its Internal Antigen in Blood LymphocytesQ40114415
Bovine lymphosarcoma.Q40123272
Prevalence and genetic profiling of virulence determinants of non-O157 Shiga toxin-producing Escherichia coli isolated from cattle, beef, and humans, Calcutta, IndiaQ40671710
Ribosome-inactivating proteins from plantsQ40800757
Recent advances in the uses and applications of ribosome-inactivating proteins from plantsQ40937318
Induction of mid-term abortion by trichosanthin in laboratory animalsQ41490342
Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP.Q41903590
Expression of receptors for verotoxin 1 from Escherichia coli O157 on bovine intestinal epitheliumQ43897032
Ribosomal Inhibitory Proteins from Plants Inhibit HIV-1 Replication in Acutely Infected Peripheral Blood Mononuclear CellsQ44263982
Relation of bovine leukosis virus production on cell growth cycleQ44325235
Permeability to inhibitors of protein synthesis in virus infected cellsQ45072452
Spontaneously proliferating lymphocytes from bovine leukaemia virus-infected, lymphocytotic cattle are not the virus-expressing lymphocytes, as these cells are delayed in G(0)/G(1) of the cell cycle and are spared from apoptosisQ45743699
Up-regulation of IL-2 receptor alpha and MHC class II expression on lymphocyte subpopulations from bovine leukemia virus infected lymphocytotic cowsQ45772615
Characterization of the blood lymphocyte population in cattle infected with the bovine leukemia virus.Q45838669
Neutralizing antibodies against Shiga-like toxins from Escherichia coli in colostra and sera of cattle.Q49232754
A new approach in the synthesis of immunotoxins: ribosome inactivating protein noncovalently bound to monoclonal antibody.Q50775410
CD4 T lymphocyte activation in BLV-induced persistent B lymphocytosis in cattle.Q54163967
Purification of recombinant Shiga-like toxin type I A1 fragment from Escherichia coli.Q54632708
Single-chain ribosome inactivating proteins from plants depurinate Escherichia coli 23S ribosomal RNA.Q54691614
High occurrence of Shiga toxin-producing Escherichia coli (STEC) in healthy cattle in Rio de Janeiro State, BrazilQ61697296
Trichosanthin, α-momorcharin and β-momorcharin: identity of abortifacient and ribosome-inactivating proteinsQ68367206
Comparison of inhibitory effect of galactose analogs on the binding and cytotoxicity of an anti-globotriaosylceramide monoclonal antibody coupled or not coupled to pokeweed antiviral proteinQ68991125
Enhanced B-lymphocyte expression of IL-2R alpha associated with T lymphocytosis in BLV-infected persistently lymphocytotic cowsQ71627423
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)327-334
P577publication date2003-01-01
P1433published inInfection and ImmunityQ6029193
P1476titleAntiviral activity of shiga toxin requires enzymatic activity and is associated with increased permeability of the target cells
P478volume71

Reverse relations

cites work (P2860)
Q38393278A systematic review and meta-analysis of the epidemiology of pathogenic Escherichia coli of calves and the role of calves as reservoirs for human pathogenic E. coli.
Q40323988Bovine Leukemia Virus and Mycobacterium avium subsp. paratuberculosis Are Not Associated with Shiga Toxin-Producing Escherichia coli Shedding in Cattle.
Q35216120Bovine immune response to shiga-toxigenic Escherichia coli O157:H7
Q79465059Differential sensitivity of viruses to the antiviral activity of Shiga toxin 1 A subunit
Q36238457Immune Response in Calves Vaccinated with Type Three Secretion System Antigens and Shiga Toxin 2B Subunit of Escherichia coli O157:H7
Q34601837Intestinal Shiga toxin-producing Escherichia coli bacteria mitigate bovine leukemia virus infection in experimentally infected sheep
Q36575980Shiga toxin 1 targets bovine leukemia virus-expressing cells
Q45408676The non-toxic A subunit of Shiga toxin type 1 prevents replication of bovine immunodeficiency virus in infected cells
Q36482722Verotoxin A subunit protects lymphocytes and T cell lines against X4 HIV infection in vitro

Search more.